Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.16 - $0.22 $2,818 - $3,874
17,613 New
17,613 $2,000
Q4 2022

Feb 14, 2023

BUY
$0.41 - $12.8 $5,505 - $171,891
13,429 New
13,429 $6,000
Q2 2022

Aug 15, 2022

BUY
$0.95 - $1.22 $31,114 - $39,957
32,752 New
32,752 $33,000
Q1 2020

May 15, 2020

SELL
$1.06 - $2.16 $13,386 - $27,278
-12,629 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$1.69 - $2.16 $21,343 - $27,278
12,629 New
12,629 $22,000
Q2 2019

Aug 14, 2019

SELL
$1.89 - $4.01 $39,330 - $83,448
-20,810 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$1.66 - $5.9 $34,544 - $122,779
20,810 New
20,810 $74,000

About Akari Therapeutics Plc


  • Ticker AKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,349,200
  • Market Cap $123M
  • Description
  • Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...
More about AKTX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.